CRE24-035: Pembrolizumab-Induced Hemophagocytic Lymphohistiocytosis in a Patient With Breast Cancer: A Case Report and Systematic Review of the Literature

Charlotte S. Walmsley, Michael Andersen, Barbara D. Lam, Deepa Rangachari, Shana Berwick, Rushad PatellJournal of the National Comprehensive Cancer Network 2024 · DOI

Abstract

"CRE24-035: Pembrolizumab-Induced Hemophagocytic Lymphohistiocytosis in a Patient With Breast Cancer: A Case Report and Systematic Review of the Literature" published on 05 Apr 2024 by National Comprehensive Cancer Network.
BibTeX
@article{walmsley2024cre,
  author = {Charlotte S. Walmsley and Michael Andersen and Barbara D. Lam and Deepa Rangachari and Shana Berwick and Rushad Patell},
  title = {{CRE24-035: Pembrolizumab-Induced Hemophagocytic Lymphohistiocytosis in a Patient With Breast Cancer: A Case Report and Systematic Review of the Literature}},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2024},
  doi = {10.6004/jnccn.2023.7307},
}

Loading related content...

Figure